CompletedPhase 3ACTRN12611000405910
Does using progesterone in threatened miscarriage increase the live birth rate?
In women with threatened miscarriage, does progesterone supplementation increase the likelihood of live birth?
Sponsor
Dr Luke McLindon
Enrollment
386 participants
Start Date
Feb 8, 2012
Study Type
Interventional
Conditions
Summary
This project will assess the effect of progesterone therapy on pregnancy outcomes in women presenting with threatened miscarriage. It is hypothesised that progesterone supplementation for early threatened pregnancy increases the live birth rate.
Eligibility
Sex: FemalesMin Age: 18 Yearss
Inclusion Criteria3
- Threatened miscarriage
- Live intra-uterine pregnancy
- Gestation less than 10 weeks + 0 days
Exclusion Criteria1
- Pregnancy as a result of Assisted Reproductive Technologies
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Progesterone pessary 400 mg nightly, until 12 weeks + 0 days
Progesterone pessary 400 mg nightly, until 12 weeks + 0 days
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12611000405910